Company profile for Vyant Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Vyant Bio’s dynamic drug discovery engine is powered by a convergence of innovative bioengineering technologies, industry-leading data science, and world-class IND-enabling development strategies—seamlessly coordinated in one reliable resource.Our powerful AnalytiX™ platform, at the intersection of human biology and machine learning, is unmatched in its ability to quickly and comprehensively analyze robust functional dat...
Vyant Bio’s dynamic drug discovery engine is powered by a convergence of innovative bioengineering technologies, industry-leading data science, and world-class IND-enabling development strategies—seamlessly coordinated in one reliable resource.Our powerful AnalytiX™ platform, at the intersection of human biology and machine learning, is unmatched in its ability to quickly and comprehensively analyze robust functional data to identify the most promising drug candidates, targets, and biomarkers via a quantified, unbiased rank order approach.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2 Executive Campus 2370 State Route 70 West, Ste 310 Cherry Hill, NJ 08002-410...
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/12/26/2801092/0/en/Vyant-Bio-Provides-Update-on-Winddown-Activities.html

GLOBENEWSWIRE
26 Dec 2023

https://www.globenewswire.com//news-release/2023/11/10/2778509/0/en/Vyant-Bio-Provides-Update-on-Winddown-Activities.html

GLOBENEWSWIRE
10 Nov 2023

https://www.globenewswire.com//news-release/2023/11/01/2771502/0/en/Vyant-Bio-Announces-Stockholder-Approval-of-Plan-of-Dissolution.html

GLOBENEWSWIRE
01 Nov 2023

https://www.globenewswire.com//news-release/2023/10/24/2765997/0/en/Vyant-Bio-Announces-Completion-of-StemoniX-Asset-Sale.html

GLOBENEWSWIRE
24 Oct 2023

https://www.globenewswire.com//news-release/2023/10/19/2763463/0/en/Vyant-Bio-Announces-Stockholder-Approval-of-Proposed-Asset-Sale-64-110-Votes-Needed-to-Approve-Plan-of-Dissolution-and-Adjournment-of-Special-Meeting-of-Stockholders.html

GLOBENEWSWIRE
19 Oct 2023

https://www.globenewswire.com//news-release/2023/10/11/2758627/0/en/Vyant-Bio-Announces-77-522-Votes-Needed-to-Approve-Sale-of-Assets-175-721-Votes-Needed-to-Approve-Winddown-of-Business-Adjournment-of-Special-Meeting-of-Stockholders.html

GLOBENEWSWIRE
11 Oct 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty